SYNULOX LACTATING COW INTRAMAMMARY SUSPENSION

Maa: Irlanti

Kieli: englanti

Lähde: HPRA (Health Products Regulatory Authority)

Osta se nyt

Lataa Valmisteyhteenveto (SPC)
12-06-2017

Aktiivinen ainesosa:

AMOXICILLIN (EQUIVALENT TO AMOXICILLIN TRIHYDRATE PH. EUR.), CLAVULANIC ACID (EQUIVALENT TO POTASSIUM CLAVULANATE PH. EUR.), PREDNISOLONE

Saatavilla:

Zoetis Ireland Limited

ATC-koodi:

QJ51RV01

INN (Kansainvälinen yleisnimi):

AMOXICILLIN (EQUIVALENT TO AMOXICILLIN TRIHYDRATE PH. EUR.), CLAVULANIC ACID (EQUIVALENT TO POTASSIUM CLAVULANATE PH. EUR.), PRE

Annos:

200/50

Lääkemuoto:

intramammary Suspension

Prescription tyyppi:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeuttinen ryhmä:

Bovine

Terapeuttinen alue:

antibacterials and corticosteroids

Käyttöaiheet:

Antibacterial

Valtuutuksen tilan:

Authorised

Valtuutus päivämäärä:

2014-11-28

Valmisteyhteenveto

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Synulox Lactating Cow Intramammary suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary suspension.
Pale cream/buff coloured oily suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (lactating cows).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use in clinical cases of mastitis including cases associated with
infections with the following pathogens:
Straphylococci (including
-lactamase producing strains)
Streptococci (including_ S.agalactiae, S.dysgalactiae_ and_ S.uberis_)
_Escherichia coli_ (including
-lactamase producing strains)
4.3 CONTRAINDICATIONS
Do not use in animals which are known to be hypersensitive to
-lactamase antibiotics.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not use in cases associated with_ Pseudomonas_.
Active substances
One syringe (3g) contains:
Amoxicillin trihydrate
equivalent to amoxicillin
200 mg
Potassium clavulanate
equivalent to clavulanic acid 50 mg
Prednisolone
10 mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_2_
_/_
_1_
_1_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_9_
_0_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Swab teat end with appropriate disinfectant before treatment.
RECOMMENDATIONS FOR PRUDENT USE
The product should be used for treatment of clin
                                
                                Lue koko asiakirja